Optimal treatment regimens for patients with bleeding disorders
Simon Brown(Royal Children's Hospital), George E. Rivard, Karen Beeton, Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Pete Lollar(Emory University), Christian S. Keßler, Christine A. Lee, Rolf Ljung(Lund University), Marilyn J. Manco‐Johnson(University of Colorado Anschutz Medical Campus), N J Goddard(The Royal Free Hospital), C Peerlinck, G. Mariani, Leon W. Hoyer(University of Minnesota), Blanchette, Silvia Bolland(National Institute of Allergy and Infectious Diseases), T W Barrowcliffe(British Society for Haematology), Anne Goodeve(University of Sheffield)
Cited by 9
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587